MiMedx Group, Inc.MDXGNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P100
Near historical high
vs 2Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM19.43%+3.7%
202418.73%+48.5%
202312.61%+416.3%
2022-3.99%-410.4%
2021-0.78%+94.8%
2020-15.11%-244.5%
2019-4.39%-189.6%
20184.90%-70.1%
201716.37%+349.4%
20163.64%-